Series C Preferred Subordination AgreementSeries C Preferred Subordination Agreement • November 19th, 2018 • Icagen, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledNovember 19th, 2018 Company Industry JurisdictionThis Subordination Agreement (the “Agreement”) is made as of August , 2018, by and between Perceptive Credit Holdings II, LP, a Delaware limited partnership, in its capacity as Administrative Agent (as hereinafter defined) for the Lenders (as hereinafter defined), Icagen, Inc., a Delaware corporation (“Parent”), and the other parties signatory hereto (each, a “Holder” and collectively the “Holders”).
ICAGEN, INC. FORM OF AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 19th, 2018 • Icagen, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledNovember 19th, 2018 Company Industry JurisdictionThis AMENDMENT TO SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of August 31, 2018, by and among Icagen, Inc., a Delaware corporation with its executive offices located at 4222 Emperor Blvd., Suite 350, Research Triangle Park, Durham, North Carolina 27703 (the “Company”), and the investors set forth on the signature pages affixed hereto (each, an “Investor” and, collectively, the “Investors”). Capitalized terms used herein without definition shall have the meaning ascribed to such terms in the Securities Purchase Agreement (the “Agreement’”) with the Company being amended hereby pursuant to which Investor acquired Units, each Unit consisting of shares of the Company’s Series C Convertible Redeemable Preferred Stock (the “Series C Preferred Shares”) and a seven year warrant (the “Warrant”) to purchase 28,571 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).